Dr. Lucielli Savegnago holds a degree in Clinical Pharmacy Analysis from the Federal University of Santa Maria (2001), a master's degree (2004), a doctorate (2007), and a post-doctorate (2008) in Toxicological Biochemistry from the Federal University of Santa Maria. In 2008, she was awarded the Women in Science/LOréal award. She was an affiliated member of the Brazilian Academy of Sciences in the area of Biological Sciences (2021-2025) and a professor at UNIPAMPA (2008–2010). Since 2010, she has been working as a Professor and Researcher at the Federal University of Pelotas - UFPEL. She works as an associate professor and permanent professor in the Postgraduate Program in Biotechnology (PPGB) at UFPel. In 2010, she founded the Neurobiotechnology Research Group (GPN) and is focused on the search for biotechnological strategies for the treatment of depression and Alzheimer's disease. She worked from 2017 to 2019 as the coordinator of the Graduate Program in Biotechnology at UFPel. She was deputy coordinator of the Graduate Program in Biotechnology - PPGB (2016–2017). Dr. Savegnago is a reviewer of high-impact journals. She was a member of the advisory committee for the Biological Sciences area of FAPERGS, as a member of the institutional committee for scientific initiation scholarships at UFPel, and a member of the ethics and animal experimentation committee at UFPel. She was vice-coordinator of the advisory committee for the Biological Sciences area at FAPERGS (2022–2024).